Adelene Q. Perkins, President & CEO at INFINITY PHARMACEUTICALS, INC. (INFI), sold 10,000 shares at $12.81 ($128K) on 2015-05-27, disclosed to the SEC on 2015-05-28.
Scheduled sale ($128k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INFI | SELL | 2018-03-07 | $14K | — | Filing → |
| INFI | SELL | 2015-06-26 | $55K | — | Filing → |
| INFI | SELL | 2015-05-15 | $122K | — | Filing → |